The Food and Drug Administration has approved a new treatment device for those diagnosed with Diabetes.

The new device is a first-of-a-kind "artificial pancreas." The device is said to help some patients better manage their disease by constantly monitoring their blood sugar and delivering insulin as needed.

The device from Medtronic called, MiniMed 670G consists of a drug pump, a sensor that measure blood sugar and a tube that delivers insulin, reports CBS.

The sensor measures blood sugar every five minutes, infusing or withholding insulin as needed. Patients will still have to manually increase insulin before meals.

MiniMed 670G is about the size of a deck of cards and can be worn on a belt or carried in a pocket.

So far, the device has been approved for Type 1 Diabetics 14 years old and older.

Medtronic says the device will cost between $6,000 and $9,000, similar to other insulin pumps.

The FDA said it approved the device based on a three-month study of more than 120 patients.